Mass immunisation to eradicate Japanese encephalitis: Real-world evidence from Guizhou Province in 2005–2021

IF 3.5 4区 医学 Q2 IMMUNOLOGY Journal of Virus Eradication Pub Date : 2024-03-01 DOI:10.1016/j.jve.2024.100366
Wan-Xue Zhang , Suye Zhao , Chunliu Pan , Yiguo Zhou , Chao Wang , Liping Rui , Juan Du , Ting-Ting Wei , Ya-Qiong Liu , Ming Liu , Qing-Bin Lu , Fuqiang Cui
{"title":"Mass immunisation to eradicate Japanese encephalitis: Real-world evidence from Guizhou Province in 2005–2021","authors":"Wan-Xue Zhang ,&nbsp;Suye Zhao ,&nbsp;Chunliu Pan ,&nbsp;Yiguo Zhou ,&nbsp;Chao Wang ,&nbsp;Liping Rui ,&nbsp;Juan Du ,&nbsp;Ting-Ting Wei ,&nbsp;Ya-Qiong Liu ,&nbsp;Ming Liu ,&nbsp;Qing-Bin Lu ,&nbsp;Fuqiang Cui","doi":"10.1016/j.jve.2024.100366","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To explore epidemiological changes of Japanese encephalitis (JE) in a long-time span and evaluate the impact of mass immunisation.</p></div><div><h3>Method</h3><p>Data on JE cases from hospitals and the county Centers for Disease Control and Prevention in Guizhou Province was collected between 2005 and 2021. Epidemiological changes were analyzed according to a series of policy implementations and the coronavirus disease 2019 (COVID-19) pandemic.</p></div><div><h3>Results</h3><p>A total of 5138 JE cases and 152 deaths were reported in Guizhou Province during 2005–2021. The average incidence and case fatality rates were 0.83/100,000 and 2.96%, respectively. The JE prevalence showed a declining trend over the years with the reduced incidence gap between age groups and narrowing of the high-epidemic regions. During the COVID-19 pandemic, the JE activity reached its nadir in 2020. The inclusion in the Expanded Program on Immunization of the JE vaccine and catch-up immunisations showed a significant impact on the JE declining incidence rate.</p></div><div><h3>Conclusions</h3><p>The implementation of JE immunisation programs has played a crucial role in controlling its spread. Continued efforts should be made to maintain high coverage of the JE vaccine and strengthen disease surveillance systems, ensuring JE effective control and eventual elimination.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 1","pages":"Article 100366"},"PeriodicalIF":3.5000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000037/pdfft?md5=b647c4e93eaf9e946d8e373c38bb3d1c&pid=1-s2.0-S2055664024000037-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virus Eradication","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2055664024000037","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To explore epidemiological changes of Japanese encephalitis (JE) in a long-time span and evaluate the impact of mass immunisation.

Method

Data on JE cases from hospitals and the county Centers for Disease Control and Prevention in Guizhou Province was collected between 2005 and 2021. Epidemiological changes were analyzed according to a series of policy implementations and the coronavirus disease 2019 (COVID-19) pandemic.

Results

A total of 5138 JE cases and 152 deaths were reported in Guizhou Province during 2005–2021. The average incidence and case fatality rates were 0.83/100,000 and 2.96%, respectively. The JE prevalence showed a declining trend over the years with the reduced incidence gap between age groups and narrowing of the high-epidemic regions. During the COVID-19 pandemic, the JE activity reached its nadir in 2020. The inclusion in the Expanded Program on Immunization of the JE vaccine and catch-up immunisations showed a significant impact on the JE declining incidence rate.

Conclusions

The implementation of JE immunisation programs has played a crucial role in controlling its spread. Continued efforts should be made to maintain high coverage of the JE vaccine and strengthen disease surveillance systems, ensuring JE effective control and eventual elimination.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过大规模免疫接种根除日本脑炎:2005-2021 年贵州省的现实证据
方法 收集2005年至2021年贵州省医院和县疾病预防控制中心的日本脑炎(JE)病例数据,根据一系列政策实施和冠状病毒病2019年(COVID-19)大流行分析流行病学变化。结果 2005-2021年贵州省共报告JE病例5138例,死亡152例。平均发病率和病死率分别为 0.83/10 万和 2.96%。随着年龄组间发病率差距的缩小和高发区范围的缩小,JE发病率呈逐年下降趋势。在 COVID-19 大流行期间,JE 活动在 2020 年达到低谷。将脊灰炎疫苗纳入扩大免疫计划和补种免疫对脊灰炎发病率的下降产生了显著影响。应继续努力保持 JE 疫苗的高覆盖率并加强疾病监测系统,确保有效控制并最终消灭 JE。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Virus Eradication
Journal of Virus Eradication Medicine-Public Health, Environmental and Occupational Health
CiteScore
6.10
自引率
1.80%
发文量
28
审稿时长
39 weeks
期刊介绍: The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions. The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections.The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.
期刊最新文献
Editorial Board Knowledge and attitude among Bangladeshi healthcare workers regarding the management and infection prevention and control of Nipah virus A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: Impact on virus-induced COX-2 expression
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1